| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artículo científico (es)
- bilimsel makale (tr)
- scienca artikolo (eo)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- artikel ilmiah (id)
- article scientifique (fr)
- বৈজ্ঞানিক নিবন্ধ (bn)
- artículu científicu espublizáu en 2012 (ast)
- наукова стаття, опублікована в березні 2012 (uk)
- مقالة علمية نشرت في مارس 2012 (ar)
- scientific article published on March 2012 (en)
- scientific article published on March 2012 (en-ca)
- scientific article published on March 2012 (en-gb)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| |
| author name string
| |
| author name string
| |
| rdfs:label
| - Targeting alpha-synuclein for the treatment of Parkinson's disease (en)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (nl)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (ast)
|
| skos:prefLabel
| - Targeting alpha-synuclein for the treatment of Parkinson's disease (en)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (nl)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (ast)
|
| name
| - Targeting alpha-synuclein for the treatment of Parkinson's disease (en)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (nl)
- Targeting alpha-synuclein for the treatment of Parkinson's disease (ast)
|
| title
| |
| title
| - Targeting alpha-synuclein for the treatment of Parkinson's disease (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.2174/187152712800269678
|
| is about
of | |
| is cites work
of | - Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
- Protective and toxic roles of dopamine in Parkinson's disease
- Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies
- Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
- Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and [...]
- Characterization of polyethylene glycol-polyethyleneimine as a vector for alpha-synuclein siRNA delivery to PC12 cells for Parkinson's disease
- Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis
- Can the disease course in Parkinson's disease be slowed?
- Impact of Plant-Derived Flavonoids on Neurodegenerative Diseases.
- Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)